DS
BJDX icon

DRW Securities’s Bluejay Diagnostics BJDX Stock Holding History

DRW Securities’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,942
Closed -$90.8K – 1260
2025
Q3 		$90.8K Buy
+14,942
New +$90.2K ﹤0.01% 1192

Other funds holding BJDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

DRW Securities's BJDX Position: Q4 2025 in Review

DRW Securities sold out of Bluejay Diagnostics (BJDX) in Q4 2025, closing a stake of 14,942 shares — an estimated $90.8K sold.

DRW Securities first reported a position in BJDX in Q3 2025 and held it in 1 quarter. The position peaked at $90.8K in Q3 2025. 8 funds tracked by Wall St. Rank hold BJDX as of Q4 2025.

  • DRW Securities reported no remaining Bluejay Diagnostics position as of Q4 2025 after selling out during the quarter.
  • DRW Securities sold 14,942 Bluejay Diagnostics shares in Q4 2025, an estimated $90.8K.
  • DRW Securities first reported a position in Bluejay Diagnostics in Q3 2025 and held it in 1 quarter.
  • DRW Securities's Bluejay Diagnostics position peaked at $90.8K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.